SOHO Stock Overview
PT Soho Global Health Tbk operates as a healthcare company in Indonesia.
Soho Global Health Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||Rp6,450.00|
|52 Week High||Rp8,500.00|
|52 Week Low||Rp4,700.00|
|1 Month Change||0%|
|3 Month Change||-3.37%|
|1 Year Change||29.78%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||184.14%|
Recent News & Updates
|SOHO||ID Pharmaceuticals||ID Market|
Return vs Industry: SOHO exceeded the ID Pharmaceuticals industry which returned -0.4% over the past year.
Return vs Market: SOHO exceeded the ID Market which returned 17% over the past year.
|SOHO Average Weekly Movement||3.5%|
|Pharmaceuticals Industry Average Movement||3.7%|
|Market Average Movement||6.2%|
|10% most volatile stocks in ID Market||12.1%|
|10% least volatile stocks in ID Market||3.0%|
Stable Share Price: SOHO is less volatile than 75% of ID stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: SOHO's weekly volatility (4%) has been stable over the past year.
About the Company
|1946||2,410||Paulino La O' Cooey||https://www.sohoglobalhealth.com|
PT Soho Global Health Tbk operates as a healthcare company in Indonesia. The company operates through Distribution, Professional Product, Consumer Health, Alliance, and Others segments. The company researches, develops, and markets specialty-focused medicines for use in the therapeutic areas of immunomodulator, respiratory, inflammation, and liver diseases; offers nonprescription brand products to treat and prevent diseases; and provides contract manufacturing services for various dosage forms, as well as distribution and logistics services.
Soho Global Health Fundamentals Summary
|SOHO fundamental statistics|
Is SOHO overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|SOHO income statement (TTM)|
|Cost of Revenue||Rp5.72t|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
|Earnings per share (EPS)||444.09|
|Net Profit Margin||7.73%|
How did SOHO perform over the long term?See historical performance and comparison
3.1%Current Dividend Yield
Is Soho Global Health undervalued compared to its fair value and its price relative to the market?
Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PB vs Industry
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: SOHO (IDR6450) is trading below our estimate of fair value (IDR8088.65)
Significantly Below Fair Value: SOHO is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: SOHO is good value based on its PE Ratio (14.5x) compared to the ID Pharmaceuticals industry average (20.7x).
PE vs Market: SOHO is good value based on its PE Ratio (14.5x) compared to the ID market (18.6x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate SOHO's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: SOHO is overvalued based on its PB Ratio (3.5x) compared to the ID Pharmaceuticals industry average (2.5x).
How is Soho Global Health forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted Pharmaceuticals & Biotech industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Soho Global Health has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Soho Global Health performed over the past 5 years?
Past Performance Score6/6
Past Performance Score 6/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: SOHO has high quality earnings.
Growing Profit Margin: SOHO's current net profit margins (7.7%) are higher than last year (2.8%).
Past Earnings Growth Analysis
Earnings Trend: SOHO's earnings have grown significantly by 49.3% per year over the past 5 years.
Accelerating Growth: SOHO's earnings growth over the past year (224.4%) exceeds its 5-year average (49.3% per year).
Earnings vs Industry: SOHO earnings growth over the past year (224.4%) exceeded the Pharmaceuticals industry 11.7%.
Return on Equity
High ROE: SOHO's Return on Equity (24%) is considered high.
How is Soho Global Health's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: SOHO's short term assets (IDR3,827.1B) exceed its short term liabilities (IDR1,995.6B).
Long Term Liabilities: SOHO's short term assets (IDR3,827.1B) exceed its long term liabilities (IDR164.2B).
Debt to Equity History and Analysis
Debt Level: SOHO is debt free.
Reducing Debt: SOHO had no debt 5 years ago.
Debt Coverage: SOHO has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: SOHO has no debt, therefore coverage of interest payments is not a concern.
What is Soho Global Health current dividend yield, its reliability and sustainability?
Dividend Score 1/6
Future Dividend Coverage
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: SOHO's dividend (3.05%) is higher than the bottom 25% of dividend payers in the ID market (1.14%).
High Dividend: SOHO's dividend (3.05%) is low compared to the top 25% of dividend payers in the ID market (4.15%).
Stability and Growth of Payments
Stable Dividend: Too early to tell whether SOHO's dividend payments have been stable as they only just started paying a dividend.
Growing Dividend: Too early to tell if SOHO's dividend payments are increasing as they only just started paying a dividend.
Earnings Payout to Shareholders
Earnings Coverage: With its high payout ratio (97.5%), SOHO's dividend payments are not well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (37.7%), SOHO's dividend payments are well covered by cash flows.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Paulino La O' Cooey
Mr. Rogelio Castillo La O' Cooey Jr., also known as Paulino, serves as the President Director and CEO of PT Soho Global Health Tbk. Mr. La O' Cooey served as Country Director of Philippines of Smile Train,...
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
PT Soho Global Health Tbk's employee growth, exchange listings and data sources
- Name: PT Soho Global Health Tbk
- Ticker: SOHO
- Exchange: IDX
- Founded: 1946
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Implied Market Cap: Rp8.186t
- Shares outstanding: 1.27b
- Website: https://www.sohoglobalhealth.com
Number of Employees
- PT Soho Global Health Tbk
- Jl. Rawa Sumur II Kav. BB No. 3
- Kawasan Industri Pulogadung
- Jakarta Raya
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/05/20 00:00|
|End of Day Share Price||2022/05/20 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.